Intensive glucose control in elderly adults [2]

JAMA

Volumn 297, Issue 20, 2007, Pages 2195-2196

  Finucane, Thomas E ^a  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; METFORMIN; ROSIGLITAZONE; SULFONYLUREA; ANTIDIABETIC AGENT;

DIABETES CONTROL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; LETTER; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; AGED; DRUG COMBINATION; NOTE; CARDIOVASCULAR DISEASE;

AGED; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; HUMANS; HYPOGLYCEMIC AGENTS; CARDIOVASCULAR DISEASES; RISK ASSESSMENT;

EID: 34249699739     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.297.20.2195-b     Document Type: Letter

References (3)

1. Abrahamson MJ. A 74-year-old woman with diabetes. JAMA. 2007;297:196-204.
2. Harris R, Donahue K, Rathore SS, Frame P, Woolf SH, Lohr KN. Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;138:215-229.
3. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive bloodglucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865. 2196